If gene therapy is ever to be considered as a treatment for Parkinson’s disease, we will have to find a way to meaningfully increase TH-positive terminals in the striatum, as motor benefits are primarily dependent on TH expression in the putamen. This evidence concerns the gene TH and Parkinson disease.